StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Free Report) in a report issued on Tuesday. The brokerage issued a sell rating on the medical research company’s stock.
Check-Cap Price Performance
Shares of NASDAQ CHEK opened at $2.30 on Tuesday. The stock has a market cap of $13.46 million, a P/E ratio of -0.76 and a beta of 0.28. Check-Cap has a 1 year low of $1.27 and a 1 year high of $4.63. The firm has a 50-day moving average of $2.25 and a 200 day moving average of $2.56.
About Check-Cap
Read More
- Five stocks we like better than Check-Cap
- How to Use the MarketBeat Dividend Calculator
- Hasbro’s Management Made All the Right Calls This Quarter
- Comparing and Trading High PE Ratio Stocks
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.